31
Views
9
CrossRef citations to date
0
Altmetric
Articles

Antiendotoxin Activity of Antimicrobial Peptides and Glycopeptides

Pages 129-133 | Published online: 18 Jul 2013

References

  • Hardaway RM. A review of septic shock. Am Surg 2000; 66: 22–29.
  • Bone RC. Pathophysiology of sepsis. Ann Intern Med 1991; 115: 457469.
  • Bone RC. Gram-negative sepsis: A dilemma of modern medicine. Clin Microbiol Rev 1993; 6: 57–68.
  • Zervos E, Norman J, Denham D, et al. Cytokine activa-tion through sublethal hemmorhage is protective against early lethal endotoxic challenge. Arch Surg 1997; 132: 1216–1221.
  • Kato T, Murata A, Ishida H, et al. Interleukin 10 reduces mortality from severe peritonitis in mice. Antimicrob Agents Chemother 1995; 39: 1336-1340.
  • Wheeler AP, Bernard GR. Treating patients with severe sepsis. N Engl J Med 1999; 340: 207–214.
  • Hancock REW Peptides antibiotics. Lancet 1997; 349: 418–422.
  • Hancock REW, Scott MG. The role of antimicrobial peptides in animal defenses. Proc Natl Acad Sci USA 2000; 97: 856–861.
  • Gough M, Hancock REW, Kelly NM. Antiendotoxin activity of cationic peptide antimicrobial agents. Infect Immun 1996; 64: 4922–4927.
  • Scott MG, Yan H, Hancock REW. Biological properties of structurally related a-helical cationic antimicrobial peptides. Infect Immun 1999; 67: 2005–2009.
  • Giacometti A, Cirioni O, Ghiselli R, et al. Effect of mono-dose intraperitoneal cecropins in experimental septic shock. Crit Care Med 2001; 29: 1666–1669.
  • Prins JM, van Deventer SJH, Kuijper EJ, Spellman P. Clinical relevance of antibiotic-induced endotoxin release. Antimicrob Agents Chemother 1994; 38: 1211–1218.
  • Gales AC, Reis AO, Jones RN. Contemporary assess-ment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative cri-teria and quality control guidelines. J Clin Microbiol 2001; 39: 183–190.
  • Foca A, Matera G, Berlinghieri MC, Liberto MC, De Sarro GB. Teicoplanin reduces in-vitro reactivity and murine lethality of Salmonella Minnesota R595 lipopolisaccaride. J Antimicrob Chemother 1992; 29: 443–446.
  • Foca A, Matera G, Berlinghieri MC. Inhibition of endo-toxin-induced interleukin 8 release by teicoplanin in human whole blood. Eur J Clin Microbiol Infect Dis 1993; 12: 940–944.
  • Wilcox MH, Winstanley TG, Spencer RC. Binding of teicoplanin and vancomycin to polymer surfaces. J Antimicrob Chemother 1994; 33: 431–441.
  • Raetz CRH. Biochemistry of endotoxins. Ann Rev Biochem 1990; 59: 129–170.
  • David SA, Silverstein R, Amura CR, Kielian T, Morrison DC. Lipopolyamines: novel antiendotoxin com-pounds that reduce mortality in experimental sepsis caused by gram-negative bacteria. Antimicrob Agents Chemother 1999; 43: 912–919.
  • Giroir B, Quint PA, Barton P, et al. Preliminary evalu-ation of recombinant amino-terminal fragment of human bac-tericidal/permeability-increasing protein in children with severe meningococcal sepsis. Lancet 1997; 360: 1439–1443.
  • Hancock REW. Therapeutic potential of cationic pep-tides. Exp Opin Invest Dis 1998; 7: 167–174.
  • Ziegler EJ, Fisher CJ, Sprung CL. Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. N Engl J Med 1991; 324: 429–436.
  • Rifkind D, Palmer JD. Neutralization of endotoxin toxi-city in chick embryos by antibiotics. J Bacteriol 1966; 92: 815–819.
  • Rogers MJ, Cohen J. Comparison of the binding of gram-negative bacterial endotoxin by polymyxin B sulphate, colistin sulphate and colistin sulphomethate sodium. Infection 1986; 4: 79–81.
  • Scott MG, Vreugdenhil AC, Buurman WA, et al. Cutting edges: cationic antimicrobial peptides block the bind-ing of lipopolysaccharide (LPS) to LPS binding protein. J Immunol 2000; 164 (2): 549–553.
  • Holzheimer RG. Antibiotic induced endotoxin release and clinical sepsis: a review. J Chemother 2001; 13 (1): 159–172.
  • Holzheimer RG, Hirte JF. Different endotoxin release and IL-6 plasma levels after antibiotic administration in surgi-cal intensive care patients. J Endotoxin Res 1996; 3: 261–267.
  • Park CB, Kim HS, Kim SC. Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorgan-isms by penetrating the cell membrane and inhibiting cellular functions. Biochem Biophys Res Com 1998; 244: 253–257.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.